Merck & Co. Shares Reserved for Future Issuance Under Stock Plans decreased by 12.0% to 66M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 12.0%, from 75M to 66M. Over 5 years (FY 2020 to FY 2025), Shares Reserved for Future Issuance Under Stock Plans shows a downward trend with a -8.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates higher potential dilution from equity-based compensation, which may impact earnings per share.
This metric tracks the number of common shares set aside for issuance to employees and directors through stock-based com...
Standard disclosure for all public companies utilizing equity-based compensation.
shares_reserved_for_stock_plans| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | 93M | 87M | 81M | 75M | 66M |
| QoQ Change | — | -6.5% | -6.9% | -7.4% | -12.0% |
| YoY Change | — | -6.5% | -6.9% | -7.4% | -12.0% |